These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33840176)

  • 21. Krebs von den Lungen-6 as a Potential Predictive Biomarker in Fibrosing Interstitial Lung Diseases.
    Lederer C; Mayer K; Somogyi V; Kriegsmann K; Kriegsmann M; Buschulte K; Polke M; Findeisen P; Herth F; Kreuter M
    Respiration; 2023; 102(8):591-600. PubMed ID: 37586349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease.
    Ko UW; Cho EJ; Oh HB; Koo HJ; Do KH; Song JW
    PLoS One; 2020; 15(12):e0244114. PubMed ID: 33332430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Krebs von den Lungen-6 as a potential biomarker for distinguishing combined pulmonary fibrosis and emphysema from chronic obstructive pulmonary disease: A retrospective study.
    Zhou A; Zhang X; Lu R; Peng W; Wang Y; Tang H; Pan P
    Heliyon; 2024 Aug; 10(15):e35099. PubMed ID: 39165953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating KL-6 levels in patients with drug induced pneumonitis.
    Ohnishi H; Yokoyama A; Yasuhara Y; Watanabe A; Naka T; Hamada H; Abe M; Nishimura K; Higaki J; Ikezoe J; Kohno N
    Thorax; 2003 Oct; 58(10):872-5. PubMed ID: 14514942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
    Wang Y; Chen S; Lin J; Xie X; Hu S; Lin Q; Zheng K; Du G; Huang X; Zhang G; Gargani L; Matucci-Cerinic M; Furst DE
    Rheumatology (Oxford); 2020 Aug; 59(8):2024-2029. PubMed ID: 31794028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.
    Shirai Y; Fukue R; Kaneko Y; Kuwana M
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease.
    Takanashi S; Nishina N; Nakazawa M; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2019 Jun; 58(6):1034-1039. PubMed ID: 30624752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y; Fu Q; Wang R; Guo Q; Bao C
    J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression.
    Stock CJW; Hoyles RK; Daccord C; Kokosi M; Visca D; De Lauretis A; Alfieri V; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Chua F; Maher TM; Abraham DJ; Ong V; Donovan J; Sestini P; Denton CP; Wells AU; Renzoni EA
    Respirology; 2021 May; 26(5):461-468. PubMed ID: 33336433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.
    Sato S; Kato T; Abe K; Hanaoka T; Yano Y; Kurosaki A; Yasuda M; Sekino T; Fujiwara K; Hasegawa K
    Oncol Lett; 2017 Jul; 14(1):776-786. PubMed ID: 28693233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren's syndrome: a case report].
    Yu JF; Jin YB; He J; An Y; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):910-914. PubMed ID: 29045979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features.
    Lanzarone N; Gentili F; Alonzi V; Bergantini L; d'Alessandro M; Rottoli P; Refini RM; Pieroni M; Vietri L; Bianchi F; Mazzei MA; Volterrani L; Perrone A; Cameli P; Bargagli E; Sestini P
    Intern Emerg Med; 2020 Oct; 15(7):1247-1254. PubMed ID: 32078140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome.
    Remuzgo-Martínez S; Atienza-Mateo B; Ocejo-Vinyals JG; Genre F; Pulito-Cueto V; Mora-Cuesta VM; Iturbe-Fernández D; Lera-Gómez L; Pérez-Fernández R; Prieto-Peña D; Irure J; Romero-Bueno F; Sanchez-Pernaute O; Alonso-Moralejo R; Nuño L; Bonilla G; Vicente-Rabaneda EF; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; ; ; Gualillo O; Cavagna L; Cifrián JM; Renzoni EA; Castañeda S; López-Mejías R; González-Gay MA
    Sci Rep; 2021 Nov; 11(1):22574. PubMed ID: 34799647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy.
    d'Alessandro M; Bergantini L; Cameli P; Pieroni M; Refini RM; Sestini P; Bargagli E
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population.
    Zheng M; Lou A; Zhang H; Zhu S; Yang M; Lai W
    Rheumatol Ther; 2021 Mar; 8(1):517-527. PubMed ID: 33586127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.
    Shigemura M; Nasuhara Y; Konno S; Shimizu C; Matsuno K; Yamguchi E; Nishimura M
    J Transl Med; 2012 Jul; 10():111. PubMed ID: 22650152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of serum Krebs von den Lungen-6 (KL-6) levels in COVID-19 pneumonia.
    Letellier A; Rolland-Debord C; Luque-Paz D; Milon A; Choinier P; Blin E; Halitim P; Bravais J; Lefèvre G; Parrot A; Piéroni L; Cadranel J
    Respir Med Res; 2023 Nov; 84():101054. PubMed ID: 37897878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitivity pneumonitis caused by Penicillium citrinum, not Enoki spores.
    Yoshikawa S; Tsushima K; Yasuo M; Fujimoto K; Kubo K; Kumagai T; Yamazaki Y
    Am J Ind Med; 2007 Dec; 50(12):1010-7. PubMed ID: 17979128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
    PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Krebs von den Lungen 6 (KL-6) levels in COVID-19 ICU patients are associated with mortality.
    Scarpati G; Baldassarre D; Boffardi M; Calabrese V; De Robertis E; Lacava G; Oliva F; Pagliano P; Pascale G; Tripepi GL; Piazza O
    J Anesth Analg Crit Care; 2022 Aug; 2(1):37. PubMed ID: 37386665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.